Interaction between PPARA genotype and &bgr;β-blocker treatment influences clinical outcomes following acute coronary syndromes

Author： Cresci Sharon Jones Philip G Sucharov Carmen C Marsh Sharon Lanfear David E Garsa Adam Courtois Michael Weinheimer Carla J Wu Jun Province Michael A Kelly Daniel P McLeod Howard L Spertus John A

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.10, 2008-10, pp. : 1403-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Medications for the treatment of acute coronary syndromes

By Brieger David B

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2843-2854

Informa Healthcare

Access to resources Recommend Favorite

Impact of Obstructive Sleep Apnoea on Clinical Characteristics and Outcomes in Patients with Acute Coronary Syndrome Following Percutaneous Coronary Intervention

By Meng S Fang L Wang C-Q Wang L-S Chen M-T Huang X-H

The Journal of International Medical Research, Vol. 37, Iss. 5, 2009-09 ,pp. : 1343-1353

Field House Publishing

Access to resources Recommend Favorite

Rivaroxaban in the contemporary treatment of acute coronary syndromes

By Alexander Deepu Jeremias Allen

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 849-857

Informa Healthcare

Access to resources Recommend Favorite

Anti-inflammatory Treatment of Acute Coronary Syndromes

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4172-4189

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Acute Coronary Syndromes in Mexico: Gaps and Opportunities to Improve Outcomes

By Leiva-Pons Jose L.

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite